Collectively, the luminal nature of the LPL-C3 tumors, the wild-type p53 activity, the high proportion of FGFR3 mutations, SHH-BMP pathway activity, and lower EMT signature all support a less-aggressive tumor type and suggest a biological explanation for the favorable prognosis of patients with these tumors. Here, TP53 is linked to neoplasm.